Table 2 Calculation sensitivity and specificity in blood samples from pancreatic cancer patients.

From: Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer

 

Pancreatic cancer

Non-pancreatic cancer

CDKN2 positive

35/85 = 0.41 (a, TP)

16/60 = 0.27 (b, FP)

CDKN2 negative

50/85 = 0.59 (c, FN)

44/60 = 0.73 (d, TN)

  1. TP: true positive, FP: false positive, FN: false negative, TN: true negative.
Back to article page